Moderna asking US, European regulators to OK its virus shots
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.
Thailand, Philippines sign for AstraZeneca COVID-19 vaccine
Thailand on Friday signed a $200 million deal to procure 26 million doses of a trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021.
First COVID-19 immunizations could arrive on December 12th
A FDA advisory committee is set to meet Dec. 10 to discuss Pfizer’s request for an emergency use authorization for its developing COVID-19 vaccine.
WHO: ‘No evidence’ remdesivir an effective treatment for hospitalized COVID-19 patients
In a press release, the WHO said there is currently “no evidence that remdesivir improves survival and other outcomes in these patients.”
FDA to livestream public meeting on Pfizer-BioNTech potential COVID-19 vaccine
The U.S. Food and Drug Administration has set a public meeting on Dec. 10 to discuss approving Pfizer and BioNTech’s experimental COVID-19 vaccine and will livestream it on YouTube, Facebook and Twitter.
Medical centers more prepared for 2nd wave of COVID-19, experts say
With COVID-19 cases surging again, Advocate Aurora Health experts look at the different factors surrounding the pandemic this time around.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Federal health officials planning to get coronavirus shots to nursing homes
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
Texas teen wins $25K for work on possible COVID-19 solution
14-year-old eighth-grader Anika Chebrolu of Frisco has won the 2020 3M Young Scientist Challenge for her study on COVID-19.